FDA Rejects Ocugen’s Application of Covaxin
The US Food and Drug Administration (FDA) has rejected the proposal for emergency use authorization (EUA) of Bharat Biotech’s Covaxin. Ocugen, which has done a...
Tag : Ocugen
Ocugen Pays $15 Million to Bharat Biotech for Covaxin Rights
Ocugen Inc, the US partner for Bharat Biotech‘s Covid-19 vaccine has announced the payment of $15 million to Bharat Biotech for the vaccine rights in...